Global H1N1 Vaccines Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
- SKU ID : GIR-GIR1807250054 12746208
- |
- Publishing Date: 27-Aug-2018
- |
- Region: Global
- |
- No. of pages: 137
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
Scope of the Report:
This report focuses on the H1N1 Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
The Americas led the global H1N1 vaccines market and is expected to reach close to USD 2 billion by 2020. Factors such as the higher incidences of H1N1 infections in the US and the affordability of treatment due to well-structured reimbursement health plans to propel this market’s growth in the region. Furthermore, the increasing use of combination vaccines and the introduction of novel vaccines is anticipated to drive the growth of this market in the Americas.
The worldwide market for H1N1 Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Market Segment by Applications, can be divided into
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
There are 15 Chapters to deeply display the global H1N1 Vaccines market.
Chapter 1, to describe H1N1 Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of H1N1 Vaccines, with sales, revenue, and price of H1N1 Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of H1N1 Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, H1N1 Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe H1N1 Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Scope of the Report:
This report focuses on the H1N1 Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
The Americas led the global H1N1 vaccines market and is expected to reach close to USD 2 billion by 2020. Factors such as the higher incidences of H1N1 infections in the US and the affordability of treatment due to well-structured reimbursement health plans to propel this market’s growth in the region. Furthermore, the increasing use of combination vaccines and the introduction of novel vaccines is anticipated to drive the growth of this market in the Americas.
The worldwide market for H1N1 Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Market Segment by Applications, can be divided into
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
There are 15 Chapters to deeply display the global H1N1 Vaccines market.
Chapter 1, to describe H1N1 Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of H1N1 Vaccines, with sales, revenue, and price of H1N1 Vaccines, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of H1N1 Vaccines, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, H1N1 Vaccines market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe H1N1 Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
